National Allergy and Asthma Research, LLC.

North Charleston, South Carolina 29420

1 studies enrolling now · 16 studies all time

What they study most

Asthma, Atopic Dermatitis, Atopic Eczema, Chronic Inducible Urticaria, Chronic Spontaneous Urticaria, Moderate-to-Severe Atopic Dermatitis, Moderate-to-severe Atopic Dermatitis, Peanut Allergy, Pruritus

Studies at this site

• A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis — Recruiting now
• Registry of Asthma Patients Initiating DUPIXENT® — Completed
• Dupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema Trial — Completed
• A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) — Completed
• Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects With Chronic Spontaneous Urticaria — Stopped early
• Tralokinumab in Combination With Topical Corticosteroids for Moderate to Severe Atopic Dermatitis - ECZTRA 3 — Completed
• Longer-term Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008) — Completed
• Phase 1b, Open-Label Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Chronic Inducible Urticaria — Completed
• A Clinical Trial of BMX-010 in Adult Subjects With Atopic Dermatitis — Stopped early
• CNP-201 in Subjects With Peanut Allergy — Stopped early
• Neuropsychologic Assessments of Dupilumab-Treated Adolescent Participants With Moderate-to-Severe Atopic Dermatitis — Completed
• A Study of CDX-0159 in Patients With Chronic Spontaneous Urticaria — Completed
• Randomized, Placebo-controlled, Multi-dose, Study Comparing Budesonide/Formoterol to Symbicort® in Asthmatic Patients — Completed
• AR101 Real-World Open-Label Extension Study — Completed
• A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis — Stopped early
• Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis — Completed